News Preview
Kymera: Over-Hyped, Or Developing Next Dupixent? We'll Find Out Very Soon
Kymera Therapeutics' potential is debated, with some analysts believing it could develop the next Dupixent.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.